Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 12.10%5.71B | ---- | 4.71%9.04B | ---- | 13.90%5.1B | ---- | 15.12%8.63B | ---- | -6.43%4.48B |
| Profit adjustment | ||||||||||
| Interest expense - adjustment | ---- | 1.92%5.8M | ---- | 19.11%17.8M | ---- | 946.88%5.69M | ---- | 35.29%14.94M | ---- | -112.44%-672K |
| Dividend (income)- adjustment | ---- | 20.26%-5.32M | ---- | 87.64%-20.65M | ---- | 93.20%-6.67M | ---- | -48.95%-167.06M | ---- | -330.93%-98.13M |
| Attributable subsidiary (profit) loss | ---- | -243.20%-74.63M | ---- | 741.34%562.07M | ---- | 39.11%-21.74M | ---- | -140.70%-87.64M | ---- | -124.82%-35.71M |
| Impairment and provisions: | ---- | -27.89%629.78M | ---- | 40.79%1.26B | ---- | 456.24%873.38M | ---- | -25.08%891.61M | ---- | -92.88%157.01M |
| -Impairment of property, plant and equipment (reversal) | ---- | 86.28%194.43M | ---- | 38.94%264.88M | ---- | --104.37M | ---- | 61.08%190.64M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | -54.28%273.68M | ---- | 3.97%658.5M | ---- | 208.48%598.59M | ---- | -16.76%633.36M | ---- | -90.27%194.05M |
| -Impairment of trade receivables (reversal) | ---- | 16.50%127.67M | ---- | 2,758.47%261.7M | ---- | 209.45%109.59M | ---- | -105.07%-9.84M | ---- | -665.95%-100.12M |
| -Impairment of goodwill | ---- | ---- | ---- | --17.19M | ---- | --17.19M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -22.07%34M | ---- | -31.57%53.01M | ---- | -30.84%43.63M | ---- | -33.64%77.46M | ---- | -45.26%63.09M |
| Revaluation surplus: | ---- | 192.01%319.3M | ---- | 66.73%-139.61M | ---- | 20.32%-347.02M | ---- | -151.81%-419.68M | ---- | 47.13%-435.54M |
| -Derivative financial instruments fair value (increase) | ---- | 231.54%390.73M | ---- | 24.75%-266.68M | ---- | 3.40%-297.04M | ---- | -158.90%-354.4M | ---- | 68.76%-307.49M |
| -Other fair value changes | ---- | -42.92%-71.43M | ---- | 294.66%127.07M | ---- | 60.97%-49.98M | ---- | -131.34%-65.28M | ---- | -179.81%-128.04M |
| Asset sale loss (gain): | ---- | -48.62%5.32M | ---- | 261.10%50.93M | ---- | 117.96%10.36M | ---- | 45.52%-31.61M | ---- | 69.26%-57.69M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 111.70%9.65M | ---- | 107.33%2.55M | ---- | 54.72%-82.44M | ---- | 81.28%-34.75M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -31.87%5.32M | ---- | -18.78%41.28M | ---- | 134.07%7.82M | ---- | -51.58%50.83M | ---- | -1,046.28%-22.94M |
| Depreciation and amortization: | ---- | 30.28%1.89B | ---- | 5.19%3B | ---- | 6.50%1.45B | ---- | 4.52%2.85B | ---- | 0.65%1.36B |
| -Amortization of intangible assets | ---- | 238.36%448.72M | ---- | -0.06%258.23M | ---- | -4.41%132.61M | ---- | 6.36%258.38M | ---- | 16.05%138.73M |
| Financial expense | ---- | -6.92%1.11B | ---- | 8.35%2.52B | ---- | 4.16%1.19B | ---- | 18.13%2.32B | ---- | 1.72%1.15B |
| Exchange Loss (gain) | ---- | -37.31%126.74M | ---- | 142.35%72.9M | ---- | 230.67%202.17M | ---- | 27.61%-172.14M | ---- | 34.14%-154.72M |
| Special items | ---- | -10.72%-146.78M | ---- | -109.08%-789.18M | ---- | -53.29%-132.57M | ---- | -4.84%-377.45M | ---- | 4.02%-86.48M |
| Operating profit before the change of operating capital | ---- | 15.02%9.58B | ---- | 15.66%15.56B | ---- | 32.75%8.33B | ---- | -1.42%13.46B | ---- | -24.06%6.27B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 30.59%-7.83B | ---- | -72.57%-5.55B | ---- | -960.79%-11.28B | ---- | -120.69%-3.22B | ---- | 23.48%-1.06B |
| Accounts receivable (increase)decrease | ---- | 26.31%-1.41B | ---- | -543.36%-1.92B | ---- | -2,106.56%-1.91B | ---- | -42.21%433.62M | ---- | 91.46%-86.54M |
| Accounts payable increase (decrease) | ---- | 64.66%9.48B | ---- | -155.80%-956.65M | ---- | 1,191.92%5.76B | ---- | 269.24%1.71B | ---- | -89.33%445.6M |
| prepayments (increase)decrease | ---- | 24.39%-4.61B | ---- | -2,723.24%-10.18B | ---- | -87.85%-6.1B | ---- | 5.17%-360.5M | ---- | 24.16%-3.25B |
| Derivative financial instruments (increase) decrease | ---- | 102.71%12.91M | ---- | -264.81%-5.32M | ---- | 10.06%-475.49M | ---- | -40.79%3.23M | ---- | 41.08%-528.68M |
| Special items for working capital changes | ---- | -114.89%-309.98M | ---- | 1,556.47%7.23B | ---- | -65.03%2.08B | ---- | 152.81%436.67M | ---- | 85.61%5.95B |
| Cash from business operations | ---- | 236.31%4.91B | ---- | -66.43%4.19B | ---- | -146.49%-3.6B | ---- | 2.15%12.47B | ---- | -3.91%7.74B |
| Other taxs | ---- | -62.91%-2.04B | ---- | -9.17%-1.68B | ---- | 2.27%-1.25B | ---- | 1.77%-1.54B | ---- | -77.60%-1.28B |
| Adjustment items of business operations | 1,411.78%6.29B | ---- | 109.20%558.15M | ---- | -94.95%415.93M | ---- | -51.54%-6.07B | ---- | -22.34%8.23B | ---- |
| Net cash from operations | 1,411.78%6.29B | 159.20%2.87B | 109.20%558.15M | -77.06%2.51B | -94.95%415.93M | -175.03%-4.85B | -51.54%-6.07B | 2.72%10.93B | -22.34%8.23B | -11.91%6.46B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -66.76%108.74M | ---- | -24.17%146.28M | -51.74%66.26M | -28.44%327.16M | -83.31%7.08M | 59.49%192.91M | 125.79%137.29M | -62.24%457.19M | 99.77%42.41M |
| Sale of fixed assets | 160.17%78.24M | 1,323.33%66.2M | -61.16%68.89K | -13.39%39.39M | 4.85%30.07M | -83.56%4.65M | -98.17%177.35K | -74.87%45.49M | -77.99%28.68M | -56.82%28.29M |
| Purchase of fixed assets | 27.92%-2.66B | 42.56%-1.53B | -5.41%-726.2M | 1.48%-6.43B | -6.39%-3.69B | 5.81%-2.66B | 43.89%-688.89M | -26.44%-6.52B | -38.45%-3.47B | -79.46%-2.83B |
| Selling intangible assets | ---- | ---- | ---- | -99.31%5K | ---- | ---- | ---- | 219.38%725K | ---- | ---- |
| Purchase of intangible assets | ---- | 36.48%-24.1M | ---- | 49.88%-144.74M | ---- | 74.96%-37.95M | ---- | -97.84%-288.76M | ---- | -7.38%-151.55M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.01%4.86M | ---- | -100.35%-854K |
| Acquisition of subsidiaries | ---- | ---- | ---- | 32.11%-90.77M | ---- | ---- | ---- | ---133.7M | ---137.48M | ---137.49M |
| Recovery of cash from investments | 54.76%20.43B | 39.88%9.8B | 23.85%7.16B | 5.19%22.01B | 50.79%13.2B | 115.55%7.01B | 96.97%5.78B | -21.79%20.92B | -14.88%8.75B | -58.11%3.25B |
| Cash on investment | -9.23%-25.69B | -41.22%-24.59B | -34.93%-10.86B | -23.85%-27.74B | -6.60%-23.52B | -6.75%-17.42B | -84.22%-8.05B | 24.50%-22.4B | 1.16%-22.06B | 6.70%-16.31B |
| Other items in the investment business | ---- | ---- | ---- | -2,630.92%-20.4M | ---- | ---- | ---- | -108.34%-747K | ---- | ---- |
| Net cash from investment operations | 43.36%-7.73B | -24.29%-16.28B | -54.87%-4.28B | -49.52%-12.3B | 16.92%-13.65B | 18.70%-13.1B | -9.16%-2.76B | -6.60%-8.23B | -32.37%-16.43B | -45.25%-16.11B |
| Net cash before financing | 89.10%-1.44B | 25.30%-13.41B | 57.87%-3.72B | -462.39%-9.8B | -61.42%-13.23B | -86.08%-17.95B | -35.13%-8.83B | -7.51%2.7B | -352.28%-8.2B | -157.04%-9.65B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 19.85%113.25B | 3.74%101.06B | 5.03%16.68B | 17.88%127.73B | 25.50%94.49B | 26.41%97.41B | -19.04%15.88B | 10.45%108.35B | 11.08%75.29B | 14.60%77.06B |
| Refund | -33.34%-85.13B | 4.62%-56.99B | -11.97%-12.99B | -26.01%-117.05B | -74.56%-63.84B | -86.32%-59.75B | 10.24%-11.6B | -2.27%-92.89B | 13.90%-36.57B | 24.05%-32.07B |
| Issuance of bonds | ---- | -84.05%93.3M | ---- | -45.43%1.09B | ---- | -60.43%585.05M | ---- | -33.42%2B | ---- | 47.84%1.48B |
| Interest paid - financing | ---- | 17.52%-1.08B | ---- | -43.97%-2.64B | ---- | -50.72%-1.31B | ---- | -149.42%-1.84B | ---- | -16.60%-870.87M |
| Dividends paid - financing | -29.22%-4.26B | 2.90%-89.88M | -16.43%-388.7M | -16.80%-2.29B | -10.12%-3.3B | ---92.56M | -3.92%-333.85M | -9.87%-1.96B | 38.82%-2.99B | ---- |
| Absorb investment income | 8.21%330.12M | -65.86%99.67M | -1.96%10M | -34.96%304.47M | -27.93%305.06M | -31.02%291.97M | -94.90%10.2M | 81.26%468.11M | 141.87%423.27M | 141.87%423.27M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---258.75M | ---- | ---258.75M | ---- | ---- | ---- | ---- |
| Other items of the financing business | -28.05%-20.74B | -102.98%-32.37B | 135.72%319.95M | 91.97%-965.05M | 14.68%-16.2B | 37.36%-15.95B | -249.83%-895.73M | 31.60%-12.01B | -25.88%-18.98B | -40.50%-25.46B |
| Net cash from financing operations | -69.85%3.46B | -49.02%10.62B | 18.67%3.63B | 196.61%5.73B | -33.22%11.47B | 1.78%20.83B | -57.33%3.06B | 119.82%1.93B | 211.78%17.17B | 184.57%20.47B |
| Effect of rate | -127.55%-41.66M | -293.04%-63.02M | -146.48%-21.55M | -33.47%80.65M | -37.07%151.23M | -90.63%32.65M | 117.10%46.36M | -54.09%121.22M | 703.99%240.3M | -5.01%348.32M |
| Net Cash | 214.09%2.01B | -196.64%-2.79B | 98.41%-91.85M | -187.64%-4.06B | -119.69%-1.77B | -73.35%2.88B | -1,014.44%-5.77B | 167.86%4.64B | 142.85%8.97B | 214.59%10.82B |
| Begining period cash | -20.44%15.5B | -20.44%15.5B | -20.44%15.5B | 32.30%19.48B | 32.30%19.48B | 32.30%19.48B | 32.30%19.48B | -30.84%14.73B | -30.84%14.73B | -30.84%14.73B |
| Cash at the end | -2.21%17.48B | -43.52%12.65B | 11.86%15.39B | -20.44%15.5B | -25.35%17.87B | -13.51%22.4B | -8.82%13.76B | 32.30%19.48B | -4.05%23.94B | 3.18%25.9B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.